INTREPId (INTermediate Risk Erection PreservatIon Trial): A randomized trial of radiation therapy and darolutamide for prostate cancer

被引：0
|
作者：
King, Martin T.
Wise, David R.
Scala, Lawrence M.
Mariados, Neil M.
Whitbeck, Amanda
Pomerantz, Mark
Bober, Sharon
Davicioni, Elai
Bubley, Glenn
Nguyen, Paul L.
机构：
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] Kaiser Permanente, Santa Clara, CA USA
[4] Associated Med Profess New York PLLC, Syracuse, NY USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
[7] GenomeDx Biosci Inc, Vancouver, BC, Canada
[8] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS384
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial
    Guler, Ozan Cem
    Onal, Cem
    EUROPEAN JOURNAL OF CANCER, 2022, 167 : 164 - 165
  • [2] RADIATION THERAPY AND IRREVERSIBLE ELECTROPORATION (RTIRE) FOR INTERMEDIATE RISK PROSTATE CANCER: A PHASE II ONGOING TRIAL
    Posada, Calderon Lina
    Oakley, Strasser
    Parwiz, Abrahimi
    Ariel, Marciscano E.
    Joseph, Osborne
    Christopher, Barbieri
    Himanshu, Nagar
    Timothy, Mcclure
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S81 - S81
  • [3] Sildenafil Citrate Does Not Impact Risk of Biochemical Recurrence in a Randomized Trial of Sexual Function Preservation with Prostate Cancer Radiation
    Haseltine, J.
    Hopkins, M.
    Kollmeier, M. A.
    Mulhall, J.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E889 - E889
  • [4] A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial)
    Houlihan, Orla A.
    Redmond, Kelly
    Fairmichael, Ciaran
    Lyons, Ciara A.
    McGarry, Conor K.
    Mitchell, Darren
    Cole, Aidan
    O'Connor, John
    McMahon, Stephen
    Irvine, Denise
    Hyland, Wendy
    Hanna, Michael
    Prise, Kevin M.
    Hounsell, Alan R.
    O'Sullivan, Joe M.
    Jain, Suneil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (03): : 594 - 609
  • [5] Acute Toxicity Following Single-Dose Radiation Therapy in the Management of Intermediate Risk Prostate Cancer: Results from a Phase 2 Randomized Trial
    Greco, C.
    Pares, O.
    Pimentel, N.
    Louro, V.
    Arcangeli, S.
    Pinzi, V.
    Possanzini, M.
    Nunes, B.
    Morales, J.
    Stroom, J.
    Viera, S.
    Fuks, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E236 - E236
  • [6] Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
    Thomas Wiegel
    Peter Albers
    Detlef Bartkowiak
    Roswitha Bussar-Maatz
    Martin Härter
    Glen Kristiansen
    Peter Martus
    Stefan Wellek
    Heinz Schmidberger
    Klaus Grozinger
    Peter Renner
    Fried Schneider
    Martin Burmester
    Michael Stöckle
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 235 - 242
  • [7] Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
    Wiegel, Thomas
    Albers, Peter
    Bartkowiak, Detlef
    Bussar-Maatz, Roswitha
    Haerter, Martin
    Kristiansen, Glen
    Martus, Peter
    Wellek, Stefan
    Schmidberger, Heinz
    Grozinger, Klaus
    Renner, Peter
    Schneider, Fried
    Burmester, Martin
    Stoeckle, Michael
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (01) : 235 - 242
  • [8] Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial)
    Andreas Boehle
    Frank Kahmann
    Thomas Oliver Henkel
    Joerg Zimmermann
    Stefan Machtens
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1271 - 1272
  • [9] Radiation Therapy for Node-Positive Prostate Cancer: It's Time for a Randomized Trial
    Nguyen, Paul L.
    ONCOLOGY-NEW YORK, 2015, 29 (02): : 116 - 117
  • [10] Re: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
    Boehle, Andreas
    Kahmann, Frank
    Henkel, Thomas Oliver
    Zimmermann, Joerg
    Machtens, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (04) : 1271 - 1272
12345